nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A 150-kDa glycoprotein isolated from Solanum nigrum L. has cytotoxic and apoptotic effects by inhibiting the effects of protein kinase C alpha, nuclear factor-kappa B and inducible nitric oxide in HCT-116 cells
|
Lee, Sei-Jung |
|
2004 |
54 |
6 |
p. 562-572 |
artikel |
2 |
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases
|
Odenike, Olatoyosi M. |
|
2004 |
54 |
6 |
p. 553-561 |
artikel |
3 |
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFβ-RII, KRAS2, TP53 and/or CDNK2A
|
Samouëlian, V. |
|
2004 |
54 |
6 |
p. 497-504 |
artikel |
4 |
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
|
Espinosa, E. |
|
2004 |
54 |
6 |
p. 546-552 |
artikel |
5 |
Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice
|
Smith, N. F. |
|
2004 |
54 |
6 |
p. 475-486 |
artikel |
6 |
Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract
|
Limtrakul, Pornngarm |
|
2004 |
54 |
6 |
p. 525-530 |
artikel |
7 |
Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study
|
Mross, Klaus |
|
2004 |
54 |
6 |
p. 514-524 |
artikel |
8 |
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors
|
Jung, Laura L. |
|
2004 |
54 |
6 |
p. 487-496 |
artikel |
9 |
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer
|
Fukuda, Minoru |
|
2004 |
54 |
6 |
p. 573-577 |
artikel |
10 |
Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro
|
Kano, Yasuhiko |
|
2004 |
54 |
6 |
p. 505-513 |
artikel |
11 |
Synergistic killing of human leukemia cells by antioxidants and trichostatin A
|
Kang, Jiuhong |
|
2004 |
54 |
6 |
p. 537-545 |
artikel |
12 |
Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer
|
Tsuji, Takashi |
|
2004 |
54 |
6 |
p. 531-536 |
artikel |